ITCI Overview
Upcoming Projects (ITCI)
-
Examining Positive Phase 3 Results for CAPLYTA in Schizophrenia Relapse Prevention from Intra-Cellular Therapies (ITCI)
Ticker: ITCI
Execute By: Dec 31, 2024
Executed Projects (ITCI)
-
Quarterly Survey: Depression Bipolar Disorder Treatments & AXSM's Auvelity and ITCI's Caplyta October 2024
Tickers: AXSM, ITCI, TAK
Executed On: Oct 18, 2024 at 03:03 PM EDT -
Examining the Phase 3 topline results from Intra-Cellular's study 502 looking at Lumateperone in patients with major depressive disorder
Ticker: ITCI
Executed On: Aug 08, 2024 at 10:00 AM EDT -
Quarterly Survey: Depression Bipolar Disorder Treatments & AXSM's Auvelity and ITCI's Caplyta July 2024
Tickers: AXSM, ITCI, TAK
Executed On: Jul 31, 2024 at 01:02 PM EDT -
Investigating the topline results from the phase 3 study 501 on Lumateperone as an adjunctive therapy for major depressive disorder.
Ticker: ITCI
Executed On: May 10, 2024 at 12:00 PM EDT -
Quarterly Survey: Depression Bipolar Disorder Treatments and AXSM's Auvelity and ITCI's Caplyta April 2024
Tickers: AXSM, ITCI, TAK
Executed On: Apr 18, 2024 at 12:59 PM EDT -
Quarterly Survey: Depression Bipolar Disorder Treatments and AXSM's Auvelity and ITCI's Caplyta January 2024
Tickers: AXSM, ITCI, TAK
Executed On: Jan 19, 2024 at 02:45 PM EST -
Quarterly Survey: Depression Bipolar Disorder Treatments and AXSM's Auvelity and ITCI's Caplyta October 2023
Tickers: AXSM, ITCI, TAK
Executed On: Nov 03, 2023 at 01:07 PM EDT -
Quarterly Survey: Depression and Auvelity and Caplyta July 2023
Tickers: AXSM, ITCI
Executed On: Jul 28, 2023 at 03:17 PM EDT -
Digging into the topline results from Study 403 evaluating Intra-Cellular's CAPLYTA (lumateperone) in patients with MDD or bipolar depression
Ticker: ITCI
Executed On: May 31, 2023 at 09:00 AM EDT -
Quarterly Survey: Depression Bipolar Disorders and Auvelity and Caplyta April 2023
Tickers: AXSM, ITCI
Executed On: Apr 14, 2023 at 03:36 PM EDT -
Quarterly Survey: Depression Bipolar Disorders and Auvelity and Caplyta
Tickers: ITCI, AXSM
Executed On: Feb 07, 2023 at 04:47 PM EST
Expired Projects (ITCI)
-
Preparing for the upcoming FDA Panel on Lumateperone for the Treatment of Schizophrenia in Adults
Ticker: ITCI
Execute By: Jul 25, 2019
Upcoming & Overdue Catalysts (ITCI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ITCI)
-
Intra-Cellular Therapies (ITC) Announces U.S. FDA Approval of CAPLYTA (lumateperone) for the Treatment of Bipolar Depression in Adults
Ticker: ITCI
Occurred on: Dec 20, 2021 -
Intra-Cellular Therapies (ITCI) Announces Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure
Ticker: ITCI
Occurred on: Jun 29, 2020 -
Intra-Cellular Therapies'(ITCI) ITI-007 - Monotherapy in Bipolar depression Phase 3 top-line data released
Ticker: ITCI
Occurred on: Jul 08, 2019 -
Intra-Cellular (ITCI) Top-Line Phase 3 Data Evaluating ITI-007 in Schizophrenia Expected By End of 2016
Ticker: ITCI
Occurred on: Sep 28, 2016 -
Intra-Cellular Therapies Reports Completion of Enrollment of ITI-007-302 Phase 3 Clinical Trial for the Treatment of Schizophrenia
Ticker: ITCI
Occurred on: Jun 30, 2016
Strategic Initiatives (ITCI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
